Cebon J - Search Results

1

Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies.

Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, Cebon J, Burgess AW, Chen WF. Wang Y, et al. Among authors: cebon j. J Immunol. 2002 Jul 15;169(2):1102-9. doi: 10.4049/jimmunol.169.2.1102. J Immunol. 2002. PMID: 12097419

2

Expression of the MAGE-1 gene in human hepatocellular carcinomas.

Chen H, Cai S, Wang Y, Zhao H, Peng J, Pang X, Zhu J, Cong X, Rui J, Leng X, Du R, Wang Y, Vaughan H, Cebon J, Burgess AW, Chen W. Chen H, et al. Among authors: cebon j. Chin Med J (Engl). 2000 Dec;113(12):1112-8. Chin Med J (Engl). 2000. PMID: 11776148

3

The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning.

Vaughan HA, St Clair F, Scanlan MJ, Chen YT, Maraskovsky E, Sizeland A, Old LJ, Cebon J. Vaughan HA, et al. Among authors: cebon j. Cancer Immun. 2004 Jul 16;4:5. Cancer Immun. 2004. PMID: 15255672

4

MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma.

Gibbs P, Hutchins AM, Dorian KT, Vaughan HA, Davis ID, Silvapulle M, Cebon JS. Gibbs P, et al. Among authors: cebon js. Melanoma Res. 2000 Jun;10(3):259-64. Melanoma Res. 2000. PMID: 10890380

5

Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.

Vaughan HA, Svobodova S, Macgregor D, Sturrock S, Jungbluth AA, Browning J, Davis ID, Parente P, Chen YT, Stockert E, St Clair F, Old LJ, Cebon J. Vaughan HA, et al. Among authors: cebon j. Clin Cancer Res. 2004 Dec 15;10(24):8396-404. doi: 10.1158/1078-0432.CCR-04-0809. Clin Cancer Res. 2004. PMID: 15623618

6

Haemopoietic growth factor control of normal and neoplastic cellular proliferation.

Burgess AW, Cebon J, Smith S. Burgess AW, et al. Among authors: cebon j. Biochem Soc Symp. 1989;55:57-68. Biochem Soc Symp. 1989. PMID: 2695090

7

A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake.

Scott AM, Lee FT, Jones R, Hopkins W, MacGregor D, Cebon JS, Hannah A, Chong G, U P, Papenfuss A, Rigopoulos A, Sturrock S, Murphy R, Wirth V, Murone C, Smyth FE, Knight S, Welt S, Ritter G, Richards E, Nice EC, Burgess AW, Old LJ. Scott AM, et al. Among authors: cebon js. Clin Cancer Res. 2005 Jul 1;11(13):4810-7. doi: 10.1158/1078-0432.CCR-04-2329. Clin Cancer Res. 2005. PMID: 16000578 Clinical Trial.

8

Monoclonal antibodies that recognize human granulocyte-macrophage colony-stimulating factor and neutralize its bioactivity in vitro.

Dempsey PJ, Layton JE, Duhrsen U, Nicola NA, Cebon J, Burgess AW, Morstyn G. Dempsey PJ, et al. Among authors: cebon j. Hybridoma. 1990 Dec;9(6):545-58. doi: 10.1089/hyb.1990.9.545. Hybridoma. 1990. PMID: 1706312

9

An HLA-A2 polyepitope vaccine for melanoma immunotherapy.

Mateo L, Gardner J, Chen Q, Schmidt C, Down M, Elliott SL, Pye SJ, Firat H, Lemonnier FA, Cebon J, Suhrbier A. Mateo L, et al. Among authors: cebon j. J Immunol. 1999 Oct 1;163(7):4058-63. J Immunol. 1999. PMID: 10491010

10

Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.

Jackson H, Dimopoulos N, Mifsud NA, Tai TY, Chen Q, Svobodova S, Browning J, Luescher I, Stockert L, Old LJ, Davis ID, Cebon J, Chen W. Jackson H, et al. Among authors: cebon j. J Immunol. 2006 May 15;176(10):5908-17. doi: 10.4049/jimmunol.176.10.5908. J Immunol. 2006. PMID: 16670298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page